(Q44869174)

7 December 2017

title

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis (English)

1 reference

7 December 2017

0 references

0 references

1 reference

0 references

Karen Manoutcharian

1

1 reference

7 December 2017

Alicia Díaz-Orea

2

1 reference

7 December 2017

Goar Gevorkian

3

1 reference

7 December 2017

Gladis Fragoso

4

1 reference

7 December 2017

Gonzalo Acero

5

1 reference

7 December 2017

Erik González

6

1 reference

7 December 2017

Aline De Aluja

7

1 reference

7 December 2017

Nelly Villalobos

8

1 reference

7 December 2017

Eduardo Gómez-Conde

9

1 reference

7 December 2017

Edda Sciutto

10

1 reference

7 December 2017

publication date

1 May 2004

1 reference

Veterinary Immunology and Immunopathology

7 December 2017

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 December 2017

volume

99

1 reference

7 December 2017

issue

1-2

1 reference

7 December 2017

page(s)

11-24

1 reference

The histopathology of porcine cysticercosis

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Filamentous phage as vector-mediated antibody delivery to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Inhibitory role of antibodies in the development of Taenia solium and Taenia crassiceps toward reproductive and pathogenic stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Vaccination against cysticercosis and hydatid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Vaccines for prevention of cysticercosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Phage displayed biomolecules as preventive and therapeutic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Cysticercosis: identification and cloning of protective recombinant antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Effective immune protection of pigs against cysticercosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Efficacy of low doses of praziquantel in taeniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Phages from landscape libraries as substitute antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Phage-display technology--finding a needle in a vast molecular haystack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

A minimized M13 coat protein defines the requirements for assembly into the bacteriophage particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Papillomavirus-like particle based vaccines: cervical cancer and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Phage display in pharmaceutical biotechnology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

7 January 2021

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

7 January 2021

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Neurocysticercosis: a major cause of neurological disease worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

Hygiene and restraint of pigs is associated with absence of Taenia solium cysticercosis in a rural community of Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2003.12.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2003.12.009

1 reference

7 December 2017

1 reference